Guard Therapeutics International AB
GUARD | FN
Overview
Corporate Details
- ISIN(s):
- SE0021181559
- LEI:
- 549300DTX7T87FGYG180
- Country:
- Sweden
- Address:
- Box 5216, 102 45 Stockholm
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Guard Therapeutics International AB focuses on developing therapies for acute kidney injuries. Their lead program addresses high unmet medical needs.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749934898&Signature=Rp-uUzRzXv7SkXbkfjJ05UMYq9wvjVNLGqS-TUuW6BcxoMF3MhMzvCT-fI2n1SlDob4vRU4yXB1BddUleX-Pd-aEaaREaQyrULkHUblbSuBRyUyH7xInm7TETuV9wYNJuaZdjiTbhy3fqJM3bNmTKoj3bEyq7tZG53VnH9nGM8HFnH1mTI22Y-~5mEICwyjWNFnIc5KULjw9rardN9u0vd57Z57fFBkOigsQGaWu-IY6-OTOrWIL0pbijFCv~mlb3cPKdtyEiLEDWeeQh5Dn3xWFVnO7ZZY252XJk~vg05sHcuLCSYL2rM9HHzUASZfayH8I4AAfqH2KWfAPJs9amw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |